Intrinsic Value of S&P & Nasdaq Contact Us

Akoya Biosciences, Inc. AKYA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.40
+86%

Akoya Biosciences, Inc. (AKYA) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 2 Buy, 7 Hold.

The consensus price target is $2.40, representing an upside of 86% from the current price $1.29.

AKYA Stock — 12-Month Price Forecast

$2.40
▲ +86.05% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Akoya Biosciences, Inc., the price target is $2.40.
The average price target represents a +86.05% change from the last price of $1.29.

AKYA Analyst Ratings

Hold
9
Ratings
2 Buy
7 Hold
Based on 9 analysts giving stock ratings to Akoya Biosciences, Inc. in the past 3 months
Rating breakdown
Buy
2 22%
Hold
7 78%
22%
Buy
2 analysts
78%
Hold
7 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message